| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 09/01/1999 | EP0938329A1 Immunogenic tlp composition |
| 09/01/1999 | EP0938328A1 Method of inhibiting fibrosis with a somatostatin agonist |
| 09/01/1999 | EP0938318A1 Tablet with controlled release of alfuzosine chlorydrate |
| 09/01/1999 | EP0938309A1 Methods for in vivo reduction of iron levels and compositions useful therefor |
| 09/01/1999 | EP0721348B1 Monoglyceride/lactate ester permeation enhancer |
| 09/01/1999 | CN1227554A Substituted 6,5-hetero-bicyclic derivatives |
| 09/01/1999 | CN1227543A Heterocyclylmethylamino derivatives of cyclobutene-3,4-diones as potassium channel modulators |
| 09/01/1999 | CN1227494A Therapeutic applications of T-BAM (CD40L) technology to treat diseases involving smooth muscle cell |
| 09/01/1999 | CN1227225A Thiazole derivatives |
| 08/31/1999 | US5945577 Nuclear transfer units for cells |
| 08/31/1999 | US5945402 Human relaxin formulation |
| 08/31/1999 | US5945398 In a hydrophilic carrier comprising propylene glycol,esterification product of vegetable oil triglyceride and polyalkalene glycol polyol and polyoxyethylene hydrogenated castor oil; free-flowing, clear, transparent |
| 08/26/1999 | WO1999042603A1 GABAB-R2a, A 7TM RECEPTOR |
| 08/26/1999 | WO1999042485A1 Mucilage, a g-protein-coupled receptor |
| 08/26/1999 | WO1999042453A1 5-substituted pyrimidine-2-yloxy carboxylic acid derivatives, the production of the same and their utilization as endothelin antagonists |
| 08/26/1999 | WO1999042448A1 Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia |
| 08/26/1999 | WO1999042445A1 Phtalimido arylpiperazines as alpha 1a receptor antagonists useful in the treatment of benign prostatic hyperplasia |
| 08/26/1999 | WO1999042444A1 Substituted isoindolones and their use as cyclic gmp modulators in medicaments |
| 08/26/1999 | WO1999042436A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted-alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 08/26/1999 | WO1999042113A1 Composition and method for the treatment of bladder cancer |
| 08/26/1999 | WO1999042105A1 Epimorphian compound and its use |
| 08/26/1999 | WO1999042101A1 Dietary control of arachidonic acid metabolism |
| 08/26/1999 | WO1999028475A9 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 08/26/1999 | WO1999028342A3 Low-voltage activated calcium channel compositions and methods |
| 08/26/1999 | WO1999026909A3 Alpha-hydroxy, -amino and -fluoro derivatives of beta-sulphonyl hydroxamic acids as matrix metalloproteinases inhibitors |
| 08/26/1999 | WO1999022720A3 Selective cyclooxygenase-2 inhibitors against premature labor |
| 08/26/1999 | DE19807423A1 New isoindolone derivatives useful as soluble guanylate cyclase activators for treating cardiovascular disorders, asthma, renal insufficiency, diabetes, cirrhosis or cognitive dysfunction |
| 08/26/1999 | CA2321296A1 Composition and method for the treatment of bladder cancer |
| 08/26/1999 | CA2321182A1 5-substituted pyrimidine-2-yloxy carboxylic acid derivatives, the production of the same and their utilization as endothelin antagonists |
| 08/26/1999 | CA2320469A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted-alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 08/26/1999 | CA2318959A1 Epimorphian compound and its use |
| 08/25/1999 | EP0937777A2 GABA receptors and their uses |
| 08/25/1999 | EP0937722A1 Benzimidazole derivatives as cyclooxygenase-2 inhibitors |
| 08/25/1999 | EP0937069A1 Piperazino derivatives as neurokinin antagonists |
| 08/25/1999 | EP0937041A1 Pure enantiomer basic aryl-cycloalkyl-hydroxycarboxylic acid esters, process for preparing the same and their use in medicaments |
| 08/25/1999 | EP0937036A1 Substituted 4-biphenyl-4-hydroxybutyric acid derivatives as matrix metalloprotease inhibitors |
| 08/25/1999 | EP0936914A1 Hydroxy-phosphinyl derivatives useful as naaladase inhibitors |
| 08/25/1999 | CN1226886A Arylcycloalkane carboxylic esters, their use, pharmaceutical compositions and preparation |
| 08/25/1999 | CN1226827A Amino acid compositions and use thereof in immunosuppression |
| 08/25/1999 | CN1226424A Slow releasing agent of tuduvanine and its preparing method |
| 08/24/1999 | US5942519 Administering androstene derivative 5-alpha reductase inhibitor |
| 08/24/1999 | US5942517 Antagonist of alpha(1c) receptors; treatment of benign prostatic hyperplasia |
| 08/24/1999 | US5942516 Endothelin receptor antagonists |
| 08/24/1999 | US5942512 Method and composition for treating erectile dysfunction |
| 08/24/1999 | US5942419 RsbW-1 encoding nucleic acids |
| 08/24/1999 | US5942405 Identifying compounds which inhibit complement receptors by mixing cells expressing surface complement receptors with a labeled compound capable of binding receptor and determining if compound inhibits interactions by signal generation |
| 08/24/1999 | CA2141475C Type 1 and type p fimbriae-adhesins isolated from novel e. coli strains, process for their preparation and uses thereof |
| 08/20/1999 | CA2249653A1 Novel compounds |
| 08/19/1999 | WO1999041387A2 Prostate-associated serine protease |
| 08/19/1999 | WO1999041282A1 Therapeutic uses of keratinocyte growth factor-2 |
| 08/19/1999 | WO1999041240A1 3,4-dihydroquinoline derivatives as nitrogen monoxide synthase (nos) inhibitors |
| 08/19/1999 | WO1999040914A1 Bicyclic pyrrole derivatives as mcp-1 inhibitors |
| 08/19/1999 | WO1999040788A1 Inotropic and diuretic effects of exendin and glp-1 |
| 08/19/1999 | WO1999030708A3 Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men and method to study the dyssynergia in male rodents |
| 08/19/1999 | WO1999030670A3 Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof |
| 08/19/1999 | DE19806438A1 New pyrimidinyloxy-propionic acid derivatives useful as endothelin receptor antagonists in treatment of e.g. cardiac insufficiency, restenosis, hypertension, kidney failure, asthma and prostate cancer |
| 08/19/1999 | DE19806348A1 3,4-Dihydrochinolin-Derivate und ihre Verwendung in Arzneimitteln 3,4-dihydroquinoline derivatives and their use in medicaments |
| 08/19/1999 | CA2320515A1 Therapeutic uses of keratinocyte growth factor-2 |
| 08/19/1999 | CA2319082A1 Bicyclic pyrrole derivatives as mcp-1 inhibitors |
| 08/19/1999 | CA2312991A1 Prostate-associated serine protease |
| 08/18/1999 | EP0935651A2 THERAPY FOR $g(a)-GALACTOSIDASE A DEFICIENCY |
| 08/18/1999 | EP0935465A1 Novel substituted imidazole compounds |
| 08/18/1999 | EP0935464A1 Inhibitors of farnesyl-protein transferase |
| 08/18/1999 | EP0792292B1 Orphan receptor |
| 08/17/1999 | US5939583 Antiarthritic agents; bone, cardiovascular, brain, nervous system disorders; antitumor and antimetastasis agents |
| 08/17/1999 | US5939560 Inhibitors of DP-mediated processes, compositions and therapeutic methods thereof |
| 08/17/1999 | US5939434 Tetrazolyl-substituted quinuclidines as substance P antagonists |
| 08/17/1999 | US5939426 Also for motion sickness and vertigo |
| 08/17/1999 | US5939411 Piperidine derivatives substituted at position 4 with new functions other than those described previously have a high affinity for neurokinin receptors and are useful for treatment of substance p and neurokinin dependent pathologies |
| 08/17/1999 | US5939405 Potassium channel modulators |
| 08/17/1999 | US5939298 Isolated polynucleotide segment having amino acid sequence homology to a known haemophilus influenzae phenylalanyl trna synthetase (alpha-subunit)protein; can be used to screen for antibacterial compounds |
| 08/12/1999 | WO1999040091A1 Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists |
| 08/12/1999 | WO1999040088A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors, in particular as urokinase inhibitors |
| 08/12/1999 | WO1999039702A2 Method for regulating size and growth of vascularized normal tissue |
| 08/12/1999 | WO1999028304A3 Pdgf receptor kinase inhibitory compounds, their preparation and compositions |
| 08/12/1999 | WO1999004822A3 New salts with beneficial organoleptic properties |
| 08/12/1999 | CA2321025A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors, in particular as urokinase inhibitors |
| 08/11/1999 | EP0935000A2 Orphan receptor |
| 08/11/1999 | EP0934937A1 Azole derivatives as superoxide radical inhibitor |
| 08/11/1999 | EP0934931A2 3-Benzylidene-2-indolinones and their analogues as tyrosine kinase activity modulators |
| 08/11/1999 | EP0934403A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
| 08/11/1999 | EP0934300A1 The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 08/11/1999 | EP0934259A1 Beta-sulfonamido hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 08/11/1999 | CN1225637A Pyrrole triazines and pyrimidines |
| 08/11/1999 | CN1225623A Inhibition of matrix metalloproteases by acetylene contg. compounds |
| 08/11/1999 | CN1225622A Substituted oxobutyric acids as matrix metalloprotease inhibitor |
| 08/11/1999 | CN1225620A Substituted 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors |
| 08/11/1999 | CN1225268A Clinical medicinal prepns. contg. flavongly coside extracted for persimmon leaves, and process for preparing same |
| 08/10/1999 | US5935973 Affinity for 5-ht1a, alpha1, alpha2 and/or d2 receptors; antidepressants, anxiolytic agents, psychoses, dyskinesias, parkinson's disease, hypotensive agents, tourette's syndrome, obsessive-compulsive behaviour, panic attacks, social phobias |
| 08/10/1999 | US5935931 Human apoptosis-related calcium-binding protein |
| 08/10/1999 | US5935852 The present invention relates to a family of proteins designated as cerberus, which appears to be a pioneer protein, with a 9 cysteine residue pattern, which is present in the embryo. |
| 08/10/1999 | US5935835 The invention relates to novel polynucleotides and polypeptides of the family of cdc-regulatory kinases, hereinafter referred to as human myt-1 kinase. |
| 08/10/1999 | US5935816 Isolated polynucleotide and process for producing lysyl trna synthetase using host cells and vectors; use is to screen for antibacterial compounds |
| 08/10/1999 | US5935814 G-protein coupled receptor family polypeptides, referred to as hfgan72y, altered nucleic acid seqences encoding it and recombinant materials and methods for its production; use in design of protocols and treatment of various infections |
| 08/05/1999 | WO1999038873A1 Phosphate derivatives of diaryl 1,3,4-oxadiazolone |
| 08/05/1999 | WO1999038854A1 Benzoate derivatives of diaryl 1,3,4-oxadiazolone |
| 08/05/1999 | WO1999038853A1 Amino acid derivatives of daryl 1,3,4-oxadiazolone |
| 08/05/1999 | WO1999038850A1 Novel alkanoic acids and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
| 08/05/1999 | WO1999038510A1 Derivatives of 1,3,4-oxadiazolone |
| 08/05/1999 | WO1999028493A3 Method for identifying inhibitors of g-protein coupled receptor hibef51 |